A surprising new study reveals that blocking a supposedly protective enzyme, Caspase-2, could actually backfire—raising the risk of chronic liver damage and cancer over time. Researchers found that without this enzyme, liver cells grow abnormally large and accumulate genetic damage, leading to inflammation, scarring, and eventually tumors, especially with age. While inhibiting Caspase-2 may offer short-term benefits, such as reducing fatty liver disease, the long-term consequences appear dangerous.
Rising Health Insurance Costs Put American Employers and Workers Under Pressure in 2026
Health insurance costs are reshaping workplace benefits and household budgets across the United States. Explore what rising premiums mean for employers and workers, why smaller businesses face added pressure, and how companies are weighing new ways to manage healthcare spending without undermining access to care.
0 Comments